3 research outputs found
Denhaminols A–H, Dihydro-β-agarofurans from the Endemic Australian Rainforest Plant <i>Denhamia celastroides</i>
Eight new dihydro-β-agarofurans,
denhaminols A–H (<b>1</b>–<b>8</b>), were
isolated from the leaves of
the Australian rainforest tree <i>Denhamia celastroides</i>. The chemical structures of <b>1</b>–<b>8</b> were elucidated following analysis of 1D/2D NMR and MS data. The
absolute configuration of denhaminol A (<b>1</b>) was determined
by single-crystal X-ray crystallography. All compounds were evaluated
for cytotoxic activity against the human prostate cancer cell line
LNCaP, using live-cell imaging and metabolic assays. Denhaminols A
(<b>1</b>) and G (<b>7</b>) were also tested for their
effects on the lipid content of LNCaP cells. This is the first report
of secondary metabolites from <i>D. celastroides.</i
Casa de Salud de Ntra. Sra. del Pilar : galeria - salón de lectura. Barcelona (San Gervasio)
No circuladaNúmero de l'editor
Identification of Gibberellic Acid Derivatives That Deregulate Cholesterol Metabolism in Prostate Cancer Cells
The naturally occurring pentacyclic
diterpenoid gibberellic acid
(<b>1</b>) was used in the generation of a drug-like amide library
using parallel-solution-phase synthesis. Prior to the synthesis, a
virtual library was generated and prioritized based on drug-like physicochemical
parameters such as log P, hydrogen bond donor/acceptor counts, and
molecular weight. The structures of the synthesized analogues (<b>2</b>–<b>13</b>) were elucidated following analysis
of the NMR, MS, UV, and IR data. Compound <b>12</b> afforded
crystalline material, and its structure was confirmed by X-ray crystallographic
analysis. All compounds were evaluated <i>in vitro</i> for
cytotoxicity and deregulation of lipid metabolism in LNCaP prostate
cancer cells. While no cytotoxic activity was identified at the concentrations
tested, synthesized analogues <b>3</b>, <b>5</b>, <b>7</b>, <b>10</b>, and <b>11</b> substantially reduced
cellular uptake of free cholesterol in prostate cancer cells, suggesting
a novel role of gibberellic acid derivatives in deregulating cholesterol
metabolism